232 related articles for article (PubMed ID: 28054393)
1. Degenerative Valvular Disease in the Cavalier King Charles Spaniel: Results of the UK Breed Scheme 1991-2010.
Swift S; Baldin A; Cripps P
J Vet Intern Med; 2017 Jan; 31(1):9-14. PubMed ID: 28054393
[TBL] [Abstract][Full Text] [Related]
2. Degenerative mitral valve disease: Survival of dogs attending primary-care practice in England.
Mattin MJ; Boswood A; Church DB; McGreevy PD; O'Neill DG; Thomson PC; Brodbelt DC
Prev Vet Med; 2015 Dec; 122(4):436-42. PubMed ID: 26058819
[TBL] [Abstract][Full Text] [Related]
3. Heritability of premature mitral valve disease in Cavalier King Charles spaniels.
Lewis T; Swift S; Woolliams JA; Blott S
Vet J; 2011 Apr; 188(1):73-6. PubMed ID: 20347358
[TBL] [Abstract][Full Text] [Related]
4. Chronic valvular disease in the cavalier King Charles spaniel in Sweden.
Häggström J; Hansson K; Kvart C; Swenson L
Vet Rec; 1992 Dec; 131(24):549-53. PubMed ID: 1481344
[TBL] [Abstract][Full Text] [Related]
5. Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8- to 10-Year Period.
Birkegård AC; Reimann MJ; Martinussen T; Häggström J; Pedersen HD; Olsen LH
J Vet Intern Med; 2016; 30(1):63-8. PubMed ID: 26578464
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of mitral valve disease in Cavalier King Charles Spaniels.
French AT; Ogden R; Eland C; Hemani G; Pong-Wong R; Corcoran B; Summers KM
Vet J; 2012 Jul; 193(1):283-6. PubMed ID: 22050842
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with disease progression in dogs with presumed preclinical degenerative mitral valve disease attending primary care veterinary practices in the United Kingdom.
Mattin MJ; Brodbelt DC; Church DB; Boswood A
J Vet Intern Med; 2019 Mar; 33(2):445-454. PubMed ID: 30565334
[TBL] [Abstract][Full Text] [Related]
8. Serum serotonin concentrations in dogs with degenerative mitral valve disease.
Arndt JW; Reynolds CA; Singletary GE; Connolly JM; Levy RJ; Oyama MA
J Vet Intern Med; 2009; 23(6):1208-13. PubMed ID: 19709352
[TBL] [Abstract][Full Text] [Related]
9. Relationship between parental cardiac status in Cavalier King Charles spaniels and prevalence and severity of chronic valvular disease in offspring.
Swenson L; Häggström J; Kvart C; Juneja RK
J Am Vet Med Assoc; 1996 Jun; 208(12):2009-12. PubMed ID: 8707674
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
Lu CC; Liu MM; Culshaw G; French A; Corcoran B
J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
[TBL] [Abstract][Full Text] [Related]
11. Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.
Markby GR; Macrae VE; Corcoran BM; Summers KM
BMC Vet Res; 2020 Sep; 16(1):350. PubMed ID: 32967675
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Swedish breeding program for cavalier King Charles spaniels.
Lundin T; Kvart C
Acta Vet Scand; 2010 Sep; 52(1):54. PubMed ID: 20863375
[TBL] [Abstract][Full Text] [Related]
13. Heart sounds and murmurs: changes related to severity of chronic valvular disease in the Cavalier King Charles spaniel.
Häggström J; Kvart C; Hansson K
J Vet Intern Med; 1995; 9(2):75-85. PubMed ID: 7760313
[TBL] [Abstract][Full Text] [Related]
14. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991).
Beardow AW; Buchanan JW
J Am Vet Med Assoc; 1993 Oct; 203(7):1023-9. PubMed ID: 8135932
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
Sudunagunta S; Green D; Christley R; Dukes-McEwan J
J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
[TBL] [Abstract][Full Text] [Related]
16. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
[TBL] [Abstract][Full Text] [Related]
17. The genetic consequences of dog breed formation-Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels.
Axelsson E; Ljungvall I; Bhoumik P; Conn LB; Muren E; Ohlsson Å; Olsen LH; Engdahl K; Hagman R; Hanson J; Kryvokhyzha D; Pettersson M; Grenet O; Moggs J; Del Rio-Espinola A; Epe C; Taillon B; Tawari N; Mane S; Hawkins T; Hedhammar Å; Gruet P; Häggström J; Lindblad-Toh K
PLoS Genet; 2021 Sep; 17(9):e1009726. PubMed ID: 34473707
[TBL] [Abstract][Full Text] [Related]
18. Platelet function and activation in Cavalier King Charles Spaniels with subclinical chronic valvular heart disease.
Tong LJ; Hosgood GL; French AT; Irwin PJ; Shiel RE
Am J Vet Res; 2016 Aug; 77(8):860-8. PubMed ID: 27463549
[TBL] [Abstract][Full Text] [Related]
19. Volumetric quantification identifies some left atrial dilations undetected by left atrium:aorta ratio measurements: A prospective echocardiographic study in 155 Cavalier King Charles Spaniels with and without degenerative mitral valve disease.
Chetboul V; Poissonnier C; Foulex P; Alvarado MP; Trehiou-Sechi É; Saponaro V; Passavin P; Desquilbet L
PLoS One; 2024; 19(3):e0300827. PubMed ID: 38547236
[TBL] [Abstract][Full Text] [Related]
20. Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Tarnow I; Kristensen AT; Olsen LH; Pedersen HD
Am J Vet Res; 2004 Dec; 65(12):1644-52. PubMed ID: 15631028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
